In proglucagon gene ( Gcg ) knockout mice, the GLP-1 receptor antagonist, exendin 9-39, led to impaired glucose tolerance when Gcg was reactivated in the pancreas, but not when intestinal Gcg was reactivated (115)
These medications have revolutionized type-2 diabetes care, where an impaired GLP-1 response to meals has been noted
Thus, this case of acromegaly supports our hypothesis that GLP-1 analogs are more effective than DPP-4 inhibitors for pasireotide-induced hyperglycemia
Similar content being viewed by others Introduction The prevalence of metabolic diseases, such as obesity and type 2 diabetes (T2D), is steadily rising worldwide, due in large part to a westernized lifestyle that favors increased energy intake of highly palatable foods coupled with decreased energy expenditure
Designed to support glucose metabolism, mood balance, and overall metabolic wellness